Miller Capital Partners’s Merck MRK Stock Holding History

Miller Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.6K	Hold	425	–	–	0.02%	169
2026 Q1	$51.1K	Hold	425	–	–	0.02%	162
2025 Q4	$44.7K	Buy	+425	New	+$39.9K	0.02%	174

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Miller Capital Partners's MRK Position: Q2 2026 in Review

Miller Capital Partners held its Merck (MRK) position steady in Q2 2026 at 425 shares worth $54.6K. The position accounts for 0.02% of the portfolio, ranked #169.

Miller Capital Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Miller Capital Partners held 425 shares of Merck worth $54.6K as of Q2 2026.
Miller Capital Partners left its Merck share count unchanged in Q2 2026.
Merck made up 0.02% of Miller Capital Partners's portfolio in Q2 2026, its #169 holding.
Miller Capital Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Miller Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.